Tumor markers. An update (Q40950328)

25 September 2017

1 reference

title

Tumor markers. An update (English)

1 reference

25 September 2017

Pamies RJ

1

1 reference

25 September 2017

Crawford DR

series ordinal

2

1 reference

25 September 2017

publication date

1 January 1996

1 reference

Medical Clinics of North America

25 September 2017

published in

1 reference

25 September 2017

volume

80

1 reference

25 September 2017

issue

1

1 reference

25 September 2017

page(s)

185-199

1 reference

Immunohistochemical assessment of tumor proliferation and volume of embryonal carcinoma identify patients with clinical stage A nonseminomatous testicular germ cell tumor at low risk for occult metastasis

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Tumor-associated antigens in effusions of malignant and benign origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Humanization of an anti-mucin antibody for breast and ovarian cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Prognostic factors for favorable outcome in disseminated germ cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

An assessment of the clinical usefulness of two serum markers, CA15 3 and HMFG 2 in localized and metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Structure and function of the Ca antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

A profile of serum CA 15-3, carcinoembryonic antigen, alkaline phosphatase, and gamma-glutamyl transferase levels in patients with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Estimates of costs and effects of screening for colorectal cancer in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

A novel serum assay for breast epithelial antigen using a fusion protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Serum mucin antigens CASA and MSA in tumors of the breast, ovary, lung, pancreas, bladder, colon, and prostate. A blind trial with 420 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

CA 494--a new tumor marker for the diagnosis of pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Natural history of breast cancer:Progression from hyperplasia to neoplasia as predicted by angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

H-ras expression, genetic instability, and acquisition of metastatic ability by rat prostatic cancer cells following v-H-ras oncogene transfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Production of placental alkaline phosphatase (PLAP) and PLAP-like material by epithelial germ cell and non-germ cell tumours in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Prostatic cancer: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Comparative study of CA242 and CA19-9 for the diagnosis of pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Production and characterization of monoclonal antibodies identifying breast tumor-associated antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Prospective investigation of tumor markers and risk assessment in early cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Application of cancer procoagulant as an early detection tumor marker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Prostate cancer screening: current trends and future implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

The usefulness of serum acid phosphatase in monitoring patients with advanced prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Prostatic cancer with bone metastases: serum alkaline phosphatase (SAP) as a predictor of response and the significance of the SAP "flare"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

A clinical, mammographic, sonographic and histologic evaluation of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Serum and immunohistochemical studies of NCC-ST-439 in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Ceruloplasmin Level in Women with Breast Disease Preliminary Results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate d

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Detection and treatment of testicular cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Molecular and cellular markers for metastatic prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Novel tumour markers: a diagnostic role in pancreatic cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Mucin-like carcinoma-associated antigen (MCA) in breast cancer: clinical experience at the National Cancer Institute of Milan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

The Incidence and Significance of Detectable Levels of Serum Prostate Specific Antigen After Radical Prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Carcinoma-associated mucin serum markers CA M26 and CA M29: efficacy in detecting and monitoring patients with cancer of the breast, colon, ovary, endometrium and cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

The probability of developing cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

Comparison of mammary serum antigen assay with mammography in patients with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970435-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(05)70435-1

1 reference

25 September 2017

1 reference